Scinovex
article Open AccessTop 10% cited

Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2

Nature Structural & Molecular Biology · 2020 · Vol. 27(9) · pp. 846–854
Jiandong HuoAudrey Le BasReinis R. RuzaHelen M. E. DuyvesteynHalina MikolajekTomas MalinauskasTiong Kit TanPramila RijalMaud DumouxPhilip N. WardJingshan RenDaming ZhouPeter J. HarrisonMiriam WeckenerDaniel K. ClareVinod K. VogiralaJulika RadeckeL. MoyniéYuguang ZhaoJavier Gilbert‐JaramilloMichael L. KnightJulia A. TreeKaren R. ButtigiegNaomi S. CoombesMichael J. ElmoreMiles W. CarrollLoïc CarriquePranav N. M. ShahWilliam JamesAlain TownsendDavid I. StuartRaymond J. OwensJames H. Naismith
SARS-CoV-2 and COVID-19 ResearchMonoclonal and Polyclonal Antibodies ResearchViral gastroenteritis research and epidemiologyNeutralizationNeutralizing antibodyVirologyViral entryAntibodyTrimerCoronavirusChemistryEpitopeBinding site

MeSH terms

BetacoronavirusAngiotensin-Converting Enzyme 2COVID-19SARS-CoV-2Amino Acid SequenceAntibodies, ViralAntibody AffinityAntigen-Antibody ReactionsEpitopesBinding, CompetitiveHumansImmunoglobulin Fc FragmentsPeptidyl-Dipeptidase AModels, MolecularPneumonia, Viral

Funding

  • Wellcome Trust
  • Diamond Light Source
  • Cancer Research UK
  • University of Oxford
  • Chinese Academy of Medical Sciences
  • Directorate for Biological Sciences
  • Medical Research Council
  • Engineering and Physical Sciences Research Council
  • Biotechnology and Biological Sciences Research Council
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2 · Scinovex